Studio City International Holdings Reports Key Share Transactions
Studio City International Holdings Ltd reports significant share transactions, indicating increased ownership by key stakeholders and potential market confidence.
Rapport Therapeutics CFO Acquires 5,500 Shares of Stock
Rapport Therapeutics CFO Troy Ignelzi acquires 5,500 shares, raising total holdings to 15,500 shares, signaling confidence in the company's future.
Enliven Therapeutics CMO Collins Helen Louise Reports Stock Moves
Collins Helen Louise, CMO of Enliven Therapeutics, reports stock transactions, indicating strategic management in the pharmaceutical sector.
Enliven Therapeutics CFO Benjamin Hohl Reports Stock Activity
CFO Benjamin Hohl of Enliven Therapeutics discloses stock transactions, reflecting active management of personal holdings and trends in the pharmaceutical sector.
Johnson Willis J Transfers Over 3 Million Shares in Trusts
Johnson Willis J transfers significant shares to trusts, reflecting changes in ownership at Copart Inc. This may influence governance and investor confidence.
Trade Desk EVP Davis Tahnil R. Reprices Stock Options
Davis Tahnil R., EVP of Trade Desk, has repriced stock options, reflecting strategic adjustments in compensation amid market conditions.
Sternlieb Paul reports sale of 8,066 shares of Enerpac stock
Sternlieb Paul, CEO of Enerpac Tool Group, reports sale of 8,066 shares, impacting executive holdings and the industrial machinery sector.
Trade Desk CEO Jeffrey Green's Stock Options Repriced
Trade Desk, Inc. announces stock option repricing for CEO Jeffrey Green, reflecting market alignment and potential industry impact.
Olmstead Reports Stock Option Repricing at Trade Desk, Inc.
Nathan Olmstead's stock option transactions at Trade Desk highlight a strategic repricing aimed at aligning employee incentives with shareholder interests.
Disc Medicine director sells shares under trading plan
Kevin Bitterman, a director at Disc Medicine, sold shares under a trading plan, reflecting strategic financial decisions in the pharmaceutical sector.
Capers Julien E. Acquires 787,300 Shares in Palisade Bio
Capers Julien E. has acquired 787,300 shares in Palisade Bio, Inc., signaling strong commitment to the biological products sector.
Pedro Batista de Lima Filho Reports Share Transactions
Pedro Batista de Lima Filho has disclosed multiple share transactions involving AXIA Energia S.A., reflecting his active role as a director and shareholder.
Erie Indemnity CFO Reports Stock Transaction
Julie Marie Pelkowski, EVP & CFO of Erie Indemnity, files a report on recent stock transactions, showcasing continued executive investment in the company.
CFO Silver Andrew Jacob acquires 25,000 stock units
CFO Silver Andrew Jacob of CRISPR Therapeutics acquires 25,000 restricted stock units, reflecting confidence in the company's future.
Hershey Trust Company Reduces Stake in Hershey Co with Sales
Hershey Trust Company has sold shares in Hershey Co, impacting its ownership stake. This move reflects trends in the sugar and confectionery industry.
Samsara Inc. CFO Kirchhoff sells shares under trading plan
Kirchhoff Benjamin Louis, Samsara Inc.'s CFO, sold 770 shares under a trading plan, reflecting ongoing management activity and confidence in the company.
CEO John McDearman Buys Shares of Wilson Bank Holding Co
John McDearman, CEO of Wilson Bank Holding Co, purchases 20 shares, boosting his confidence in the bank's future performance amid the national commercial banking landscape.
Innventure CFO Acquires 1.8 Million Shares in Stock Move
Innventure, Inc.'s CFO Eric Stober has acquired 1.8 million shares, marking a significant stock transaction that may influence the blank checks industry.
CEO Patel Rahul G. sells 4,302 shares of Synaptics Inc
Patel Rahul G., CEO of Synaptics Inc, sold 4,302 shares under a trading plan, reflecting executive activity in the semiconductor industry.
CFO Brian Williams acquires 13,129 shares in MSD Investment
CFO Brian Williams of MSD Investment Corp. acquires over 13,000 shares, signaling confidence in the company's future amid market fluctuations.